Both in Pharmaceuticals
Bristol-Myers Squibb vs ZOETIS
Over the past year BMY returned +35.8% and ZTS returned −44.8%; their daily moves had a correlation of 0.23.
BMY +35.8% ZTS −44.8%Growth of $1, one year, split-adjusted
| Metric | BMY | ZTS |
|---|---|---|
| Price | $62.48 | $79.72 |
| Market cap | $127.71B | $32.94B |
| Today | +1.78% | +1.17% |
| 1 month | +1.7% | +15.4% |
| 6 months | +7.3% | −30.2% |
| Year to date | +15.8% | −36.6% |
| 1 year | +46.7% | −44.6% |
| Revenue growth (YoY) | +5.7% | −0.2% |
| Gross margin | 71.3% | 72.7% |
| Net margin | 25.6% | 28.0% |
| P/E (TTM) | 13.8× | 12.6× |
| Price / sales | 2.6× | 3.5× |
| Net cash | -$32.05B | -$7.37B |
| Dividend yield | 4.03% | 2.66% |
| Volatility (60d) | 27.3% | 30.8% |
| Short % of float | 2.4% | 4.2% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).